Alzheimer's Drug Could Increase Part B Premiums for Everyone A newly approved drug to slow the progression of Alzheimer's disease is drawing criticism for it's ,000 price tag, especially given its lack of proven effectiveness. Aduhelm stirred controversy when the Food and Drug Administration's own expert advisory panel was nearly unanimous in opposing the drug's approval due to mixed results in studies of effectiveness..The Social Security Cost-Of-Living Adjustment is likely to be the first target for cuts. Most deficit plans in recent years propose tying the annual inflation boost to a more slowly - growing consumer price index known as the chained CPI. The new tax legislation, in fact, adopts the chained CPI to adjust tax brackets and the new expanded standard deduction. That will mean the standard deduction will grow more slowly than before and that people will wind up in higher tax brackets, or a greater portion of their income will be subject to tax, more quickly than before. For retirees, the chained CPI would mean lower COLAs, as well - if Congress extends the change to Social Security..However, concern is growing that the Medicare Part B premium increase, which the Social Security Administration deducts directly from Social Security benefits, could consume a substantial amount of any COLA increase next year. Legislation enacted by Congress last year restricted the 2021 Medicare Part B premium from increasing more than .90 per month due to the very low COLA increase of just 1.3 percent, a result of extremely low inflation due to the COVID-19 recession. The basic Part B premium is 8.50 per month in 202"With a high COLA increase in 2022, Part B premiums might make a catch-up jump, especially as people make up visits to get healthcare services that were postponed due to the pandemic," Johnson says..A recent report by the Office of Inspector General of the Department of Health and Human Services has also found that high price drugs are affecting federal spending on drugs and increasing federal payments for Medicare Part D catastrophic coverage. Once people hit the catastrophic level of Part D coverage, beneficiaries pay a 5% coinsurance for drugs while the Federal Government pays the vast majority of the remaining costs. But there is no limit. The Inspector General's report said that federal payments for catastrophic coverage in 2015 exceeded .2 billion in 2015, which is more than triple the amount paid in 20Incredibly, only ten high-priced drugs accounted for nearly one-third of all drug spending in catastrophic coverage in 2015..Alexandria, VA Seniors will get one of the lowest cost-of-living adjustment paid in the past decade next January. But even so, COLAs remain a key target in post-election deficit reduction efforts, warns The Senior Citizens League, one of the nation's largest nonpartisan seniors groups. A plan that would slow the growth in annual COLAs is a key provision of major deficit reduction plans quietly under consideration in Congress..The Medicare Part A outlook has worsened due to both the financial impacts of COVID-19 and the high levels of people out of work. Nationwide business closures, layoffs and salary cuts, have significantly reduced the amount of revenues received by the Medicare HI trust fund over the past year, while payments to hospitals were increased 20% by emergency legislation for COVID-related care, and the elimination of cost sharing associated with COVID treatments..Members of Congress reached a last-minute deal to avert the Fiscal Cliff on Tuesday, temporarily preventing a combination of tax increases and automatic spending cuts from going into effect. In addition, Thursday, January 3rd marked the first day of the 113th Congress..pricey, especially since you may pay for it years before you use it. Some.Because it means new legislation to reduce the costs of prescription drugs is not likely to be passed this year and will have to await the start of the next Congress in January of 202In addition, as we've explained in the last couple of updates, the executive announcements the President issued regarding prescription drugs are not clear about what drugs they cover and even if things get clarified it is highly unlikely seniors will see a reduction in drug prices this year. And, of course, the major drug companies are strongly opposed to orders and are fighting to change them.
